Hypothalamic-Pituitary Axis Involvement in Primary Central Nervous System Lymphoma.

J Clin Endocrinol MetabSep 16, 2026

Carolina Sager-La Ganga, Víctor Navas-Moreno, Fernando Sebastián-Valles et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined endocrine dysfunction related to the hypothalamic-pituitary axis in 99 adult patients with primary central nervous system lymphoma (PCNSL). The study found that 89.7% of patients had gonadal axis involvement and 89.2% had thyroid axis involvement. Hypothalamic tumors were linked to a higher likelihood of combined endocrine dysfunction (odds ratio = 9.47).

Key findings

  • Diffuse large B-cell lymphoma comprised 84% of PCNSL cases studied.
  • Isolated adenohypophyseal involvement was seen in 46% of patients.
  • 89.7% of patients experienced gonadal axis dysfunction.
  • Persistent endocrinopathy was more common in patients with progressive disease.

Why it matters

Understanding the prevalence and patterns of endocrine dysfunction in PCNSL is crucial for clinicians, as it can lead to significant complications if unrecognized. Routine screening for hormonal disturbances can improve patient management and outcomes.

Source

Published in J Clin Endocrinol Metab. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.